Description
Resiquimod, an imidazoquinoline compound, is a TLR7/TLR8 synthetic agonist that can be used as a vaccine adjuvant to improve antigen-specific antibody production. Resiquimod is known to activate immune cells and upregulate the levels of cytokines like TNF-α, IL-6, IL-12, and IFN-α.
Key application(s): Vaccines
| CAS No. | 144875-48-9 |
| Shipping Condition | Dry Ice |
| Store At | -20°C |